[Contribution of diuretics to the treatment of hypertension in patients with CKD].
Ura
Nobuyuki
N
Yamaji
Izumi
I
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000145:classification / Q000627:therapeutic use*; D002908:Chronic Disease; D004232:Diuretics / Q000145:classification / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology*; D007674:Kidney Diseases / Q000188:drug therapy* / Q000209:etiology*; D016032:Randomized Controlled Trials as Topic; D012084:Renin-Angiotensin System / Q000502:physiology
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D004232:Diuretics